Francesco Parlati

All filings by Francesco Parlati on record concern Calithera Biosciences, Inc., in the capacity of senior executive. We count 13 filings; the first trade dates from 20 February 2018 and the latest from 21 January 2022.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 25 January 2022: a share grant, in Calithera Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.